ORIONPHARM Orion Pharma Ltd
Pharmaceuticals & Chemicals
Tk 25.1 as of 2026-11-12 14:07:08
Rank 289 of all scored
Data completeness 70%
Data completeness 70%
Override: Avoid. Last year was a net loss.
Score breakdown
Consistency 45
Profitability 0
Solvency 50
Valuation 38
Weights: consistency 30%, profitability 30%, solvency 20%, valuation 20%; then risk flags add or subtract points. Full method
Why this score
Strengths
- Valuation Trades near book value (P/NAV 0.3x)
Concerns
- Consistency EPS rose in only 0 of 4 years (erratic or cyclical)
- Consistency Net loss in 1 of the last 5 years
- Profitability Average ROE only 1.79% (below 10%: capital not working hard)
- Profitability Last year was a net LOSS of Tk 41.53 cr
- Valuation No P/E: the company is loss-making
Notes
- Solvency Debt/equity 1.3x (healthy but risky)
Risk flags
- Category Z (poor/defaulting: gambling favourite, avoid for long-term)
- Mid cap (Tk 200-1,000 cr)
- Within 9.61% of its 52-week low: check WHY before treating it as cheap
Valuation
P/E
P/E audited
P/E current
P/B
NAV per share
EPS (last audited year)
Graham fair value
Margin of safety
52-week range
9.6% above the low, 24.4% below the high. Near the low is only interesting if profit is intact (see concerns above) and the fall has a temporary cause.
Quality and growth
ROE
ROE avg
ROE min
Profit CAGR
Profit YoY
Net profit
EPS up
Loss years (last ~5)
Dividends and safety
Div years
Dividend yield
Payout
Cash div
D/E
Loans/MCap
Size, liquidity and ownership
MCap
Free float
Daily turnover
Sponsor %
Inst. %
Public %
Foreign %
Shareholding
- Sponsor/director 32%
- Institution 22.1%
- Foreign 0.1%
- Public 45.8%
Audited history
| Year | EPS (Tk) | NAV/share | Net profit (cr) | Cash div % | Bonus % |
|---|---|---|---|---|---|
| 2021 | 4.01 | 79.76 | 94 | 12 | 0 |
| 2022 | 3.62 | 82.53 | 85 | 10 | 0 |
| 2023 | 2.74 | 88.99 | 64 | 10 | 0 |
| 2024 | 1.36 | 92.05 | 32 | 10 | 0 |
| 2025 | -1.77 | 86.09 | -42 | — | — |
Fiscal year ends June. EPS, NAV and profit are as audited by the company and published by DSE. Financials last fetched: 14/11/2026.
Shariah screen (partial)
Business screen and the debt ratio (loans / market cap 436.4%, limit 33%) are automated. Interest income (under 5% of revenue) and cash/investment ratios must be checked in the annual report.
Educational, not investment advice. Verify on DSE and StockNow before making any decision.